Wikipedia:Good article reassessment/Acamprosate/1

Acamprosate

Article (edit | visual edit | history) · Article talk (edit | history) · Watch • Watch article reassessment page

Result: Delist. This could have been individually delisted. It manifestly fails many criteria, e.g. WP:LEAD as well as the issues below. Geometry guy 23:10, 24 February 2008 (UTC)

My main concerns are that the article broad enough and that it goes into unnecessary detail. Specifically, the section detailing the results of a single study is too much detail for an encyclopedia, and was recommended for removal with the original GA comments. Without that section, the entire article is only three paragraphs long, one of which is a quote from the FDA. While there's no rule against GA stubs, but I'm sure this subject could be significantly expanded. --jwanders^Talk 06:55, 11 February 2008 (UTC)

• Delist. The article isn't broad enough. It doesn't address the drug's commercial status -- for example, sales volume, how many people use the drug, competitors/alternatives. Majoreditor (talk) 20:31, 11 February 2008 (UTC)

• Delist per nomination reasoning. Broadness criterion is not met (e.g. usage information, development information, etc.) Article is also heavy on WP:JARGON (e.g. the only real explaination of its function is "by blocking glutaminergic N-methyl-D-aspartate receptors, while gamma-aminobutyric acid type A receptors are activated"; that sort of phrasing needs to be explained for the layman). ЭLСОВВОLД _talk 20:50, 11 February 2008 (UTC)